PuraPharm Corporation Limited (1498.HK) HKSE

0.37

+0.005(+1.37%)

Updated at December 05 01:30PM

Currency In HKD

Valuation

Market Cap217.28M
Enterprise Value568.25M
P/E Ratio-3.74
PEG Ratio0.42
Price/Sales Ratio0.42
Price/Book Ratio1.42
Enterprise/Revenue1.45
Enterprise/EBITDA48.04

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.11
Operating Margin-0.13

Management Effectiveness

Return On Assets-0.06
Return On Equity-0.36

Income Statement

Revenue382.09M
Revenue/Share0.88
Gross Profit205.14M
EBITDA17.35M
Net Income-35.44M
Diluted EPS-0.09

Balance Sheet

Total Cash49.89M
Total Cash/Share0.13
Total Debt374.45M
Total Debt/Equity3.68
Current Ratio0.52
Book Value Per Share0.26

Price History

52-Week Change-40.16
52-Week High0.66
52-Week Low0.34
Moving Average 50 Days0.41
Moving Average 200 Days0.47

Statistics

Average Volume203,393
Shares Outstanding394.94M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor18:17
Last Split DateJanuary 29, 2020